Krystal Biotech Announces First Quarter 2026 Financial and Operating Results
Go back to Krystal Biotech Announces First Quarter 2026 Financial and Operating Results| (NASDAQ: KRYS) | Delayed: 339.51 +2.49 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $337.02 | 52 Week High | $ | |||
| Open | $337.44 | 52 Week Low | $ | |||
| Day High | $341.07 | P/E | N/A | |||
| Day Low | $335.72 | EPS | $ | |||
| Volume | 8,943 | |||||

